開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
MASU: Bank of Japan expects to continue raising interest rates while current financial conditions remain accommodative.
2026-09-10
MASU: Bank of Japan expects to continue raising interest rates while current financial conditions remain accommodative.
返回
其他消息
2026-09-09
市場消息:日本主要反對黨表示將解散。
市場消息:日本主要反對黨表示將解散。
2026-09-10
CITIC Securities says since early 2026 China's innovative-drug market has seen rapid domestic volume growth. Interim results from leading innovators show fast revenue expansion driven by new products and biopharma firms are moving into a profitability inflection. Overseas programs are entering Phase III/registration-study stages, and several upcoming international conferences create concentrated data catalysts. The firm highlights three investor priorities: (1) leading internationalized innovato
CITIC Securities says since early 2026 China's innovative-drug market has seen rapid domestic volume growth. Interim results from leading innovators show fast revenue expansion driven by new products and biopharma firms are moving into a profitability inflection. Overseas programs are entering Phase III/registration-study stages, and several upcoming international conferences create concentrated data catalysts. The firm highlights three investor priorities: (1) leading internationalized innovators poised for global value realization; (2) top domestic innovators entering a new product-ramp growth phase; (3) pipeline assets with global potential whose internationalization may accelerate value realization. CITIC maintains an Outperform rating on the sector.
Chat with us
, powered by
LiveChat